These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1093324)

  • 1. [Use of ftorafur for the treatment of 3d-4th stage].
    Plaude RK; Osman VI; Tabachnik BI; Purinia IZh; Gutman EKh
    Vopr Onkol; 1975; 21(3):44-7. PubMed ID: 1093324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the effects of ftorafur and 5-fluorouracil in breast cancer (author's transl)].
    Karev NI; Blochina NG; Voznyj EK; Persin MP
    Cas Lek Cesk; 1975 Jul; 114(29):903-6. PubMed ID: 1098776
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of Ftorafur (author's transl)].
    Rieche K; Matthes ML
    Arch Geschwulstforsch; 1975; 45(5):496-501. PubMed ID: 1212068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer].
    Karev N; Blokhina N; Voznyi E; Perscin M
    Minerva Med; 1974 Jul; 65(52):2811-4. PubMed ID: 4846402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endoxan in ovarian cancer].
    Campodónico I; Soldati A; Rodríguez A
    Rev Chil Obstet Ginecol; 1974; 39(3):87-9. PubMed ID: 4620179
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
    Miller AB; Klaassen DJ; Boyes DA; Dodds DJ; Gerulath A; Kirk ME; Levitt M; Pearson JG; Wall C
    Can Med Assoc J; 1980 Sep; 123(5):365-71. PubMed ID: 7020903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of ftorafur (pyrimidine-deoxyribose n1-2'-furanidyl-5-fluorouracil).
    Valdivieso M; Bodey GP; Gottlieb JA; Freireich EJ
    Cancer Res; 1976 May; 36(5):1821-4. PubMed ID: 1268838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinoma.
    Long HJ; Nelimark RA; Su JQ; Garneau SC; Levitt R; Goldberg RM; Poon MA; Kugler JW
    Gynecol Oncol; 1994 Aug; 54(2):180-3. PubMed ID: 8063243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [1st experiences in the treatment of ovarian tumors with Peptichemio].
    Natale N; Mangioni C; Remotti G
    Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of ovarian tumors].
    Pérez Manga G; Madrigal Alonso L; Beca Figuier JM; Ureña Castro G
    Acta Oncol (Madr); 1976; 11(1):27-32. PubMed ID: 952206
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term chemotherapy with FT-207 for ovarian cancer (author's transl)].
    Sugimori H; Tanaka M; Jimi S; Watanabe E; Kato Y; Morita T; Shigyo R; Yamashita H; Nishimura A; Kawakami M; Toyota Y; Tsukamoto N; Matsuyama T; Taki I
    Nihon Gan Chiryo Gakkai Shi; 1981 Aug; 16(4):633-40. PubMed ID: 6799596
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
    Pouillart P; Bretaudeau B; Palangie T; Jouve M; Garcia-Giralt E; Asselain B
    Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group.
    Emons G; Ortmann O; Teichert HM; Fassl H; Löhrs U; Kullander S; Kauppila A; Ayalon D; Schally A; Oberheuser F
    Cancer; 1996 Oct; 78(7):1452-60. PubMed ID: 8839551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
    Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simultaneous radio-chemotherapy of advanced epithelial ovarian cancer--results after three years (author's transl)].
    Szepesi T; Kärcher KH; Seitz W; Kogelnik HD; Reinartz G; Janisch H; Szalay S
    Wien Klin Wochenschr; 1981 Apr; 93(8):256-61. PubMed ID: 6167078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endolymphatic polychemotherapy of ovarian cancer].
    Pankov AK; Sidorenko IuS; Il'inskaia EG; Ogorodnikova LS; Zubkova TV
    Vopr Onkol; 1981; 27(1):84-8. PubMed ID: 6779424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined administration of futraful and esquinone for the treatment of advanced ovarian cancer].
    Inoue S; Fukuda O; Tajima C; Tokunaga T; Nakayama M; Maeyama M
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1226-30. PubMed ID: 6820911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.
    Hakes TB; Daghestani AN; Dougherty JB; Weiselberg L; Raymond V
    Cancer Treat Rep; 1985 May; 69(5):559-60. PubMed ID: 3859369
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antitumor action of preparation No. 31 in malignant tumors of the ovaries (a clinical cytological study)].
    Kotova DG; Lipova VA
    Vopr Onkol; 1979; 25(3):24-7. PubMed ID: 373239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.